Evaluate [hlca]    
Efficacy [qlco]    
Safety [hcpp]    
Evolution [genf]    
Renal function [ortf]    
Initiation [menp]    
Reduction [npop]    
de novo [idcn]    
Liver transplant recipient [fndg]    
Study Protocol [inpr]    
Introduction [hlca]    
Calcineurin Inhibitors [phsu]    
LED [mnob]    
Improved [qlco]    
Survival Rates [qnco]    
Liver transplant recipient [fndg]    
Long Term [tmco]    
Calcineurin Inhibitors [phsu]    
HIGH RISK [qlco]    
CHRONIC RENAL FAILURE [dsyn]    
Neurotoxicity [inpo]    
de novo [idcn]    
MALIGNANCIES [neop]    
Hepatitis C Viral infection [virs]    
HEPATOCELLULAR CARCINOMA [neop]    
Several [qnco]    
Protection [fndg]    
viral replication [celf]    
MALIGNANCY [neop]    
Progression [patf]    
FIBROSIS [patf]    
PREVENT [phsu]    
nephrotoxicity [inpo]    
Calcineurin inhibitor [phsu]    
Reduction [npop]    
compromise [fndg]    
Efficacy [qlco]    
Study [mnob]    
Evaluate [hlca]    
Effects [qlco]    
Initiation [menp]    
de novo [idcn]    
Liver transplant recipient [fndg]    
Methods [inpr]    
Design [acty]    
ONGOING [idcn]    
Multicentric [spco]    
OPEN LABEL [resa]    
Controlled Study [resa]    
de novo [idcn]    
Liver transplant recipient [fndg]    
centers [spco]    
GERMANY [geoa]    
Patients [podg]    
Randomized [resa]    
RATIO [qnco]    
7 days [tmco]    
Post [tmco]    
Transplantation [topp]    
Receive [qlco]    
Trough [qnco]    
Level 3 [inpr]    
Reduced [qlco]    
Trough [qnco]    
Levels [qlco]    
Standard [qlco]    
Trough [qnco]    
Levels [qlco]    
ENTER [ftcn]    
Run-in Period [tmco]    
3-5 days [fndg]    
Post [tmco]    
Transplantation [topp]    
Run-in Period [tmco]    
Patients [podg]    
Treated [ftcn]    
Induction Therapy [topp]    
LOCAL [spco]    
practice [menp]    
Randomization [resa]    
Stratified [qlco]    
Hepatitis C virus status [clna]    
End Stage Liver Disease [dsyn]    
Scores [qnco]    
Transplantation [topp]    
Primary [qlco]    
Objective [inpr]    
Study [mnob]    
Exhibit [inpr]    
SUPERIOR [spco]    
Renal function [ortf]    
Estimated Glomerular Filtration Rate [lbpr]    
Assessed [acty]    
Modification of diet in renal disease formula [inpr]    
Reduced [qlco]    
Compared [acty]    
Standard [qlco]    
objectives [inpr]    
Treated [ftcn]    
BIOPSY [diap]    
Proven [qlco]    
Acute Rejection [fndg]    
graft loss [patf]    
DEATH [orgf]    
Incidences [qnco]    
Components [mnob]    
Composite [qlco]    
Efficacy [qlco]    
End Point [qlco]    
Renal function [ortf]    
Estimated Glomerular Filtration Rate [lbpr]    
Various [irda]    
Formula [inpr]    
Modification [ftcn]    
diet renal disease [topp]    
Chronic Kidney Disease [dsyn]    
Epidemiology [bmod]    
Collaboration [socb]    
Formula [inpr]    
PROTEINURIA [fndg]    
adverse events [patf]    
Serious Adverse Event [fndg]    
Severity [qlco]    
CYTOMEGALOVIRUS [virs]    
Hepatitis C Viral Infections [virs]    
Hepatitis C viruses [virs]    
Related [qlco]    
FIBROSIS [patf]    
Discussion [topp]    
Study [mnob]    
Aims [idcn]    
SUPERIOR [spco]    
Renal function [ortf]    
Efficacy [qlco]    
Safety [hcpp]    
de novo [idcn]    
Liver transplant recipient [fndg]    
Receive [qlco]    
Reduced [qlco]    
Compared [acty]    
Standard [qlco]    
Study [mnob]    
Evaluate [hlca]    
Antiviral [phsu]    
Benefit [qnco]    
Initiation [menp]    
